See published letter to New York Times:
Published: September 3, 2012
To the Editor:
“Too Many Bone Tests for Some, and Too Few for Others” (The Consumer. Aug. 28) neglects to mention one effective and well-tolerated treatment for postmenopausal women under 65 who are at high risk for osteoporosis: hormone replacement therapy. The reduction in fracture risk associated with use of hormone therapy is comparable to that from bisphosphonate drugs, and its use addresses the most salient cause of this disease that so disproportionately affects older women: loss of estrogen.
Yael Swica, M.D.
Manhattan